Cough, Cold and Allergy (Hay Fever) Remedies in Mexico

Published by: Euromonitor International

Published: Feb. 1, 2008 - 44 Pages

Table of Contents

OTC HEALTHCARE IN MEXICO

Executive Summary

Pharmaceutical Players Struggle To Maintain Share

Success Is Based on Lobbying Doctors

Socio-economic Trends Favour OTC Healthcare Over the Forecast Period

Key Trends and Developments

Seguro Popular Promises Health Coverage for the Neglected

Generics Face An Uphill Battle

Farmacias Similares Remains Strong

Socio-economic Trends Favour OTC Healthcare

OTC Sales Expand Along With Retail Growth

Market Indicators

Table 1 Life Expectancy at Birth 2001-2006

Market Data

Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006

Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006

Table 4 OTC Healthcare Company Shares by Retail Value 2002-2006

Table 5 OTC Healthcare Brand Shares by Retail Value 2003-2006

Table 6 Penetration of Private Label by Sector 2002-2006

Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006

Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006

Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011

Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Generics

Consumer Expenditure on Health Goods and Medical Services

Table 11 Consumer Expenditure on Health Goods and Medical Services 2001-2006

Definitions

Sources

Summary 1 Research Sources

LOCAL COMPANY PROFILES - MEXICO

Bayer De México SA De Cv

Strategic Direction

Key Facts

Summary 2 Bayer de México SA de CV: Key Facts

Summary 3 Bayer de México SA de CV: Operational Indicators

Company Background

Production

Summary 4 Bayer de México SA de CV: Production Statistics 2006

Competitive Positioning

Summary 5 Bayer de México SA de CV: Competitive Position 2006

Boehringer Ingelheim Promeco SA De Cv

Strategic Direction

Key Facts

Summary 6 Boehringer Ingelheim Promeco SA de CV: Key Facts

Summary 7 Boehringer Ingelheim Promeco SA de CV: Operational Indicators

Company Background

Production

Competitive Positioning

Summary 8 Boehringer Ingelheim Promeco SA de CV: Competitive Position 2006

GlaxoSmithKline México SA De Cv

Strategic Direction

Key Facts

Summary 9 GlaxoSmithKline México SA de CV: Key Facts

Summary 10 GlaxoSmithKline México SA de CV: Operational Indicators

Company Background

Production

Competitive Positioning

Summary 11 Summary GlaxoSmithKline México SA de CV: Competitive Position 2006

Laboratorios Liomont SA De Cv

Strategic Direction

Key Facts

Summary 12 Laboratorios Liomont SA de CV: Key Facts

Summary 13 Laboratorios Liomont SA de CV: Operational Indicators

Company Background

Production

Summary 14 Laboratorios Liomont SA de CV: Production Statistics 2006

Summary 15 Laboratorios Liomont SA de CV: Production Capacity by Format

Competitive Positioning

Summary 16 Summary Laboratorios Liomont SA de CV: Competitive Position 2006

Merck-méxico SA

Strategic Direction

Key Facts

Summary 17 Merck-México SA: Key Facts

Summary 18 Merck-México SA: Operational Indicators

Company Background

Competitive Positioning

Summary 19 Merck-México SA: Competitive Position 2006

Novartis Farmacéutica SA De Cv

Strategic Direction

Key Facts

Summary 20 Novartis Farmacéutica SA de CV: Key Facts

Summary 21 Novartis Farmacéutica SA de CV: Operational Indicators

Company Background

Production

Competitive Positioning

Summary 22 Novartis Farmacéutica SA de CV: Competitive Position 2006

Pfizer SA De Cv

Strategic Direction

Key Facts

Summary 23 Pfizer SA de CV: Key Facts

Summary 24 Pfizer SA de CV: Operational Indicators

Company Background

Competitive Positioning

Summary 25 Pfizer SA de CV: Competitive Position 2006

Procter & Gamble De México SA De Cv

Strategic Direction

Key Facts

Summary 26 Procter & Gamble de México SA de CV Key Facts

Summary 27 Procter & Gamble de México SA de CV: Operational Indicators

Company Background

Production

Summary 28 Procter & Gamble de México SA de CV: Production Statistics 2006

Competitive Positioning

Summary 29 Procter & Gamble de México SA de CV: Competitive Position 2006

Wyeth SA De Cv

Strategic Direction

Key Facts

Summary 30 Wyeth SA de CV: Key Facts

Summary 31 Wyeth SA de CV: Operational Indicators

Company Background

Production

Summary 32 Wyeth SA de CV: Production Statistics 2006

Competitive Positioning

Summary 33 Wyeth SA de CV: Competitive Position 2006

COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN MEXICO

Headlines

Trends

Competitive Landscape

Prospects

Sector Data

Table 12 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2001-2006

Table 13 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2001-2006

Table 14 Sales of Decongestants by Type: Value 2001-2006

Table 15 Sales of Decongestants by Type: % Value Growth 2001-2006

Table 16 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2001-2006

Table 17 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2001-2006

Table 18 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2001/2006

Table 19 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Retail Value 2002-2006

Table 20 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Retail Value 2003-2006

Table 21 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2006-2011

Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2006-2011

Abstract

Euromonitor International's Cough, Cold and Allergy Products in Mexico report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2001-2006), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market- be they new product developments, distribution or pricing issues. Forecasts to 2011 illustrate how the market is set to change.

Product coverage: decongestants, cough remedies, pharyngeal preparations, medicated confectionery, combination products, child-specific products, antihistamines

Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?

• Get a detailed picture of the cough, cold and allergy (hayfever) industry
• Identify factors driving change
• Understand the competitive environment, the market’s major players and leading brands
• Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai and Vilnius and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning.


Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.